HCA Healthcare, Inc.

HCA Healthcare, Inc.

HCANYSE / NASDAQHealthcareLarge cap

$475.57+$15.24 (+3.3%)

Last close · Data as of Nov 20, 2026

Market cap
$80.3B
P/E
11.8x
EV / EBITDA
8.2x
Revenue
$75.6B
Net margin
9.0%
ROCE
27.0%

-0.1% over the last year

HCA Healthcare, Inc. price, 1Y

Daily closes.

Go deeper

Technical chart: candles, 28 indicators including moving averages, RSI and MACD, drawing tools and five colour themes

Open technical chart
Open technical chartCandles, 28 indicators, drawing tools

Performance

Price return, before dividends, to the 20 Nov 2026 close.

1M
+2.1%
3M
+17.1%
6M
+19.9%
1Y
-0.1%
5Y
+98.9%

52-week range

Day change +$15.24 (+3.3%) from $460 to $476 · Last close Nov 20, 2026

Best weekday to invest, historically

The same weekly amount in HCA, bought on each weekday since 2021.

News & filings

What HCA Healthcare filed, who traded, and what's next

How to read this

"News & filings" lists what the company itself has put on record with regulators, who inside it traded, the news that names it, and the next date we know of. Filings and releases are first-hand; news is third-party and may be thin for smaller companies. A day of insider filings is one row. Nothing here is a recommendation.

AI Summary

US Stock

ConcernShareholders' equity is negative: liabilities exceed assets.

Strengths (1)

  • Return on capital employed of 27.0%.
  • Shareholders' equity is negative, so return on equity and debt to equity are not shown.

Prices to the 20 Nov 2026 close · Financial year: fiscal 2025

Rule-based from financial data. Not advice.

About the company

HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States.

Read moreShow less

HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States. The company owns, manages, and operates hospitals, ASCs, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, as well as rehabilitation and physical therapy centers, physician practices, home health agencies, hospices, outpatient physical therapy providers, home and community-based services providers, and various other facilities. Its general and acute care hospitals offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic services, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.

Sector
Healthcare
Shares outstanding
224.6M

Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.

Valuation

Market cap
$80.3B
P/E
11.8x
P/B
-13.3x
EV / EBITDA
8.2x
EV / Sales
1.7x
P/S
1.1x
52-week high
$545.13
52-week low
$361.32

Profitability

Operating margin
15.8%
Net margin
9.0%
EBITDA margin
20.6%
ROE
-112.6%
ROCE
27.0%
ROA
11.2%
Asset turnover
1.25

Growth

Revenue
$75.6B
Revenue growth, 1Y
7.1%
Revenue CAGR, 3Y
7.9%
Net profit growth, 1Y
17.8%
Free cash flow
$7.7B

Solvency

Current ratio
0.97
Debt / Equity
-8.08
Debt / Assets
0.80
CFO / Net profit
1.86
Cash / Market cap
1.3%

Where the revenue went

Of every $100 of FY2025 revenue, $9 was left as net income.

HCA Healthcare, Inc. income statement flow, FY2025
HCA Healthcare, Inc. income statement flow, FY2025: flows
FromToAmount
RevenueCost of revenue$44.2B
RevenueGross profit$31.4B
Gross profitOperating expenses$19.4B
Gross profitOperating income$12.0B
Operating incomePretax income$9.8B
Operating incomeInterest and other expense$2.1B
Pretax incomeTax and other$3.0B
Pretax incomeNet income$6.8B

Revenue and net profit

Revenue grew 7.1% in FY2025; net profit is the dashed line.

HCA Healthcare, Inc. revenue and net profit by fiscal year
HCA Healthcare, Inc. revenue and net profit by fiscal year
DateRevenueNet profit
FY2022$60.2B$5.6B
FY2023$65.0B$5.2B
FY2024$70.6B$5.8B
FY2025$75.6B$6.8B

Cash flows

FY2025: $12.6B from operations, $7.7B free after investment (dashed).

HCA Healthcare, Inc. operating and free cash flow by fiscal year
HCA Healthcare, Inc. operating and free cash flow by fiscal year
DateOperating cash flowFree cash flow
FY2022$8.5B$4.1B
FY2023$9.4B$4.7B
FY2024$10.5B$5.6B
FY2025$12.6B$7.7B

Growth

Latest fiscal year 2025: each figure with its change over the year before.

Revenue
$75.6B+7.1%1Y
EBITDA
$15.6B+12.3%1Y
Net profit
$6.8B+17.8%1Y
Cash from operations
$12.6B+20.2%1Y
Free cash flow
$7.7B+36.4%1Y
Revenue CAGR, 3Y
7.9%
Net profit CAGR, 3Y
6.3%
YearRevenueEBITDANet profitFCFROERevenue growth 1YNet profit growth 1Y
FY2025$75.6B$15.6B$6.8B$7.7B-112.6%+7.1%+17.8%

Monthly returns

Month-by-month returns of HCA across the years, with the seasonal pattern.

Balance sheet

What the company owns and owes at the end of FY2025.

LineFY2025
Assets$60.7B
Liabilities$63.5B
Equity-$2.8B
Retained earnings-$5.7B
Minority interest$3.3B

Market cap against peers

8 peers: same sector, nearest by size.

Peers map

Healthcare companies placed by value, growth and quality; HCA highlighted.

P/E against peers

HCA trades at 11.8x earnings against a peer median of 20.8x (a 43% discount).

Peer comparison

Same-sector peers by market cap, with the median.

CompanyMarket capP/EP/BROEEV/EBITDA
HCA Healthcare, Inc.HCAthis companyP/E ↓ discount$80.3B11.8x-13.3x-112.6%8.2x
Medtronic plcMDT$105.2B22.6x2.2x9.7%14.3x
McKesson CorporationMCK$91.0B19.1x-41.9x-219.2%13.3x
Elevance Health, Inc.ELV$88.9B15.7x2.0x12.9%—
The Cigna GroupCI$74.2B12.5x1.8x14.3%10.2x
Boston Scientific CorporationBSX$72.6B25.1x3.0x12.0%16.1x
Regeneron Pharmaceuticals, Inc.REGN$65.9B14.6x2.1x14.4%11.3x
Cencora, Inc.COR$52.6B33.8x34.9x103.1%14.9x
Edwards Lifesciences CorporationEW$50.4B46.9x4.9x10.4%33.2x
Peer median—20.8x2.1x12.4%14.3x

Year-to-date ROI

HCA since 1 January, against earlier years.

Historical volatility

HCA's day-to-day swings over 30, 60 and 180 days.

Financial statements

Income statement, balance sheet and cash flow as reported, grouped into plain-language lines.

Consolidated figures in USD, fiscal years, newest first.

Operating margin by fiscal year

HCA Healthcare, Inc. operating margin by fiscal year
HCA Healthcare, Inc. operating margin by fiscal year
DateOperating margin
FY202215.0%
FY202314.8%
FY202414.9%
FY202515.8%
LineFY2025
Cost of revenueCost Of Revenue$44.2B
Gross profitGross Profit$31.4B
Operating expensesOperating Expense$19.4B
Other operating expensesOther Operating Expenses$15.9B
Depreciation and amortisationDepreciation And Amortization In Income Statement$3.5B
Depreciation, amortisation and depletionDepreciation Amortization Depletion Income Statement$3.5B
Total expensesTotal Expenses$63.6B
Operating incomeOperating Income$12.0B
Pretax incomePretax Income$9.8B

Learn while you research

Academy chapters picked for HCA Healthcare, Inc. and the metrics on this page.

  1. 01 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
  2. 02 Value InvestingA P/E of 11.8 could be a value opportunity, or a value trap. Know the difference.7 min read
  3. 03 Sector Analysis MattersHealthcare valuation is driven by pipelines and regulation, not just numbers.6 min read
  4. 04 Essential Stock RatiosP/E, P/B, EV/EBITDA, what they mean and when to use each.7 min read
  5. 05 How to Read a Cash-Flow StatementProfit can be manipulated; cash flow rarely lies.7 min read
Browse the full Equiscale Academy →